UnitedHealth Group Stock Prediction and Forecast [UNH]

AI-generated source summary

The analysis indicates a bearish outlook for UnitedHealth Group (UNH). Short-term and long-term moving averages suggest selling pressure, with a recent 3-month MACD sell signal. Volume has decreased, reducing overall risk. Technical analysis points to resistance at $336.50 and $352.31, with support at $308.49. Analysts have a mixed view, with some giving a 'buy' rating based on positive growth prospects, while others are cautious due to recent performance and market conditions. The stock is currently trading at a P/E ratio of 16.60, considered potentially undervalued. Recent insider trading activity shows a net buying trend, with several purchases noted.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   07 Nov 2025, 04:45 UTC

   The analyst published the original source item.

2. First prediction resolved

   12 Nov 2025, 14:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   12 Nov 2025, 14:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:48 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:15 UTC

   Tahlil Plus began monitoring the extracted predictions.